16 drugmakers rebound in first half

Published: 2013-08-14 07:00:00

Updated: 2013-08-14 07:00:00

The nation’s sixteen leading drug manufacturers may have bottomed out in earnings in the first half of this year as their sales and operating profits have shown signs of improvement on the back of robust sales of flagship products, data showed Monday.

Last year, the government forced the domes...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK